Argos Therapeutics Inc. (Nasdaq: ARGS) and its partner Cellthera Pharm, a subsidiary of Pharmstandard focused on personalized therapeutics, announced the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE